Liquidity and management's plans (Details Textual) - USD ($)			3 Months Ended		6 Months Ended	9 Months Ended
	Jul. 14, 2015	May. 08, 2015	Jun. 30, 2015	Mar. 31, 2015	Mar. 31, 2015	Sep. 30, 2015	Sep. 30, 2014
Conversion of Stock [Line Items]
Proceeds from Notes Payable						$ 1,741,667	$ 0
Stock And Warrants Issued During Period Shares Initial Public Offering		2,850,000
Stock And Warrants Issued During Period Shares Initial Public Offering Purchase Price Per Unit		$ 6.00
Proceeds From Issuance Of Units Under Initial Public Offering Gross		$ 17,100,000
Proceeds From Issuance Of Units Under Initial Public Offering Net		12,100,000
Debt Conversion, Original Debt, Amount		$ 2,100,000
Conversion of Stock, Shares Issued		7,374,852
Proceeds from Issuance of Common Stock						4,958,335	0
Debt Conversion, Converted Instrument, Amount						300,000	0
Merck Global Health Innovation Fund LLC | AdvanDx Inc [Member]
Conversion of Stock [Line Items]
Proceeds From Issuance Of Shares And Debt	$ 6,000,000
Common Stock
Conversion of Stock [Line Items]
Stock And Warrants Issued During Period Shares Initial Public Offering		422,500
Proceeds From Issuance Of Units Under Initial Public Offering Gross		$ 17,100,000
Proceeds From Issuance Of Units Under Initial Public Offering Net		12,100,000
Common Stock | Merck Global Health Innovation Fund LLC
Conversion of Stock [Line Items]
Sale of Stock, Price Per Share	$ 4.40
Sale of Stock, Number of Shares Issued in Transaction	1,136,364
Proceeds from Issuance of Common Stock	$ 5,000,000
Initial public offering
Conversion of Stock [Line Items]
Proceeds From Issuance Of Units Under Initial Public Offering Net		$ 12,100,000
Debt Conversion, Converted Instrument, Amount						2,100,000	$ 0
Convertible Notes Payable
Conversion of Stock [Line Items]
Proceeds from Convertible Debt						1,500,000
Short-term Demand Notes
Conversion of Stock [Line Items]
Proceeds from Notes Payable					$ 2,300,000	800,000
Repayments of Notes Payable			$ 200,000
Debt Conversion, Converted Instrument, Amount				$ 300,000
Promissory Note | Merck Global Health Innovation Fund LLC
Conversion of Stock [Line Items]
Debt Instrument, Face Amount	$ 1,000,000
Promissory Note | Common Stock | Merck Global Health Innovation Fund LLC
Conversion of Stock [Line Items]
Proceeds From Issuance Of Common Stock And Notes Payable						$ 6,000,000